Las Piñas Doctors Hospital
Las Piñas, 1742, Philippines
NCT Number: NCT05310396
The purpose of this study is to demonstrate the efficacy of the nutrient blend in a starter infant formula (IF) and follow up infant formula (FUF) in improving the neurocognitive and behavioural outcomes among formula-fed infants randomized to the experimental formula (EF) versus the control formula (CF).
Looking for future studies?
Notify Me6 week–8 week
All sexes
Interventional
Not applicable
Las Piñas, 1742, Philippines
This is a prospective, randomized, controlled, double-blind, 2-arm parallel-group clinical trial in the Philippines. Subjects will be recruited from a single centre; in case of insufficient recruitment, more sites will be added to the study. The clinical trial is composed of two parts: a double-blind interventional period and a follow-up period. The first period is the double-blind intervention phase from enrolment (V1) until age 12 months (V5). The intervention will be provided only during this double-blind phase. The second period is a non-interventional follow-up period from age 12 months until age 24 months.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cow's milk-based infant formula with a specific blend of nutrients at pre-defined levels
Cow's milk-based infant formula with standard nutritional composition
Time frame: 12 months
Change in the scores on the Cognitive subscale. The scores range from 40 to 160 and higher scores indicate a better cognitive outcome
Time frame: 6 months, 9 months, 12 months, and 24 months
Infant Language, motor, socio-emotional, adaptive behaviour, and cognitive scores will be assessed
Time frame: 4 months, 6 months, 9 months, and 12 months
Developmental status of infants' visual attention will be assessed using the infant Gap-Overlap task
Time frame: 4 months, 6 months, 9 months, and 12 months
Infant's quality of attention will be assessed using the infant visual habituation task as augmented with heart rate
Time frame: Words and Gestures (long form) at 12 months and Words and Sentences (long form) at 24 months
Assessed using the MacArthur-Bates Communicative Development Inventories
Time frame: 24 months
Assessed using the A-not-B Invisible Displacement Task
Time frame: 24 months
Assessed using the Behavior Rating Inventory of Executive Function-Preschool version. The questionnaire consists of scales such as Inhibit, Shift, Emotional Control, working memory, plan and organize and Indexes such as Inhibitory Self control, Flexibility Index, Emergent metacognition index and Global Executive Composite. T scores are used to interpret the child's level of executive functioning on the BRIEF-P. scores provide information about a child's scores relative to the scores of children in the standardization sample
Time frame: 1.5-2 months, 6 months, and 12 months
Assessed using the Infant Behaviour Questionnaire Revised Short Form. The questionnaire assess dimensions of temperament along 14 scales on a 7-point Likert scale on behavior occurrence, with 1 being never and 7 being always (Activity level, Distress to limitations, Approach, Fear, Duration of orienting, smiling and laughter, vocal reactivity, Sadness, Perceptual sensitivity, High-intensity pleasure, Low-intensity pleasure, Cuddliness, Soothability, Falling Reactivity/Rate of Recovery From Distress)
Time frame: 24 months
Child temperament will be assessed using the Early Childhood Behavior Questionnaire- Short Form. The questionnaire measures 18 discrete traits embedded within three higher-order factors on a 7-point Likert scale on behavior occurrence, with 1 being never and 7 being always. Negative Affect (Discomfort, Fear, Frustration, Motor Activation, Sadness, Perceptual Sensitivity, Shyness, Soothability), Surgency (Impulsivity, Activity Level, High Intensity Pleasure, Sociability, Positive Anticipation), and Effortful Control (Inhibitory Control, Attention Shifting, Low Intensity Pleasure, Cuddliness, and Attentional Focusing).
Time frame: 1.5-2 months, 6 months, 12 months, and 24 months
Infant daytime and night-time sleep patterns, parent perception, and sleep-related behaviours will be assessed using the Brief Infant Sleep Questionnaire
Time frame: 1.5-2 months (but before starting study formula), and just prior to 6 months, and 12 months
Overall fecal microbiota composition, diversity, microbiota community types will be assessed using next generation sequencing (NGS) technology
Time frame: 1.5-2 months (but before starting study formula), 6 months, and 12 months
Fecal markers of immune and gut barrier, such as but no restricted to total secretory IgA (sIgA), lipocalin-2, calprotectin, and α-1-antitrypsin will be assessed by ELISA
Time frame: 1.5-2 months, 6 months, and 12 months
Assessed using Infant Gastrointestinal Symptom Questionnaire. The questionnaire comprises of 13 questions assessed on a 5-point Likert Scale with overall scores of 13 (best) to 65 (worst) for overall GI symptoms
Time frame: 24 months
Assessed using Toddler Gut Comfort Questionnaire. The questionnaire comprises of 10 questions assessed on a 6-point scale for frequency and severity, ranging from 1 (None or Not at all) to 6 (Always or Very strong).
Time frame: 1.5-2 months, 4 months, 6 months, 9 months, 12 months and 24 months
Head circumference measured in cm
Time frame: 1.5-2 months, 4 months, 6 months, 9 months, 12 months and 24 months
Weight measured in grams
Time frame: 1.5-2 months, 4 months, 6 months, 9 months, 12 months and 24 months
Length/Height measured in cm
Time frame: 1.5-2 months, 4 months, 6 months, 9 months, 12 months and 24 months
Weight and height will be combined to report BMI in kg/m2
Time frame: 1.5-2 months, 4 months, 6 months, 9 months, 12 months and 24 months
Weight-for-age, height-for-age, weight-for-height, head circumference-for-age, BMI-for-age, weight and height velocity
Time frame: 1.5-2 months, 13 months, and additionally at 23.8 months and 24 months
Collected as part of standard adverse events reporting for safety assessment including medication use and paper Infant Illness Diary continuously from enrolment until V5 (12 mo).
Time frame: Completed by the parent on a weekly basis beginning on the first day of intervention (1 day after V1 after the stool collection)
Assessed using Study Compliance Diary
Time frame: Completed at home just prior to clinic visits at 6 months, 12 months and 24 months
Will be assessed using a 24-hour Dietary Recall completed by the parent / caregiver
Time frame: 1.5-2 months and 4 months
Assessed using an Edinburgh Postnatal Depression Scale. The questionnaire comprises of 10 questions. Responses are scored 0, 1, 2 and 3 based on the seriousness of the symptom. The total score is obtained by adding together the scores for each of the 10 items. Scores above 12 or 13 are likely to be indicative of possible depression
Time frame: 1.5-2 months, 6 months, 12 months and 24 months
Assessed using a Parenting Stress Index-Short Form. The questionnaire comprises of thirty-six items divided into three domains: Parental Distress (PD), Parent-Child Dysfunctional Interaction (P-CDI), and Difficult Child (DC), which combine to form a Total Stress scale. Each subscale consists of 12 items rated from 1 (strongly disagree) to 5 (strongly agree), with subscales scores ranging from 12 to 60. A Total score is calculated by summing the three subscales scores, ranging from 36 to 180. Scores of 90 or above may indicate a clinical level of stress.
Société des Produits Nestlé (SPN)
Industry
Efficacy of a Nutrient Blend Comprised of Specific Nutrients in Improving Neurocognitive and Behavioural Outcomes in Infants: a Randomized, Controlled, Intervention Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03513744
Infant Nutrition
Mannheim, Germany
View Trial DetailsNCT03278847
Asphyxia Neonatorum, Body Temperature Changes
London, United Kingdom
View Trial DetailsNCT03400605
Behavior, Breast Feeding
Toronto, Ontario, Canada
View Trial DetailsNCT03305406
Behavior, Breast Feeding
Toronto, Ontario, Canada
View Trial Details